Weibo Cai, Ph.D., Director of the Molecular Imaging and Nanotechnology Laboratory and Assistant Professor of Radiology and Medical Physics, has taken two advisory positions which will enable him to be involved with important developments in pharmaceutical biotechnology and molecular imaging.
Dr. Cai was invited to serve on the Editorial Board of Current Pharmaceutical Biotechnology. The publication aims to cover the latest developments in pharmaceutical biotechnology, and each issue of the journal contains a series of timely in-depth reviews, research articles and letters written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of the specialty.
Dr. Cai will also serve as an ad hoc member of two National Institutes for Health (NIH) study sections in 2014. The two sections, Clinical Molecular Imaging and Probe Development (CMIP) and Medical Imaging (MEDI), both will take place in St. Louis in early June.